{"id":"W3018517995","doi":"10.1136/annrheumdis-2020-217139","title":"EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":276,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Cilag; Pharmacyclics; Chugai Pharmaceutical; LEO Pharma; Regeneron Pharmaceuticals; Gilead Sciences; European League Against Rheumatism; Celgene; Biogen; Sanofi; Amgen; Pfizer; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Immunotherapy; Cancer immunotherapy; Adverse effect; Cancer; Ipilimumab; Immunology; Intensive care medicine; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1017129,0.001487753,0.002761578,0.005144295,0.002146368,0.007366268,0.005646421,0.01898155,0.008379133],"category_scores_gemma":[0.09323991,0.0008388007,0.00683434,0.002996675,0.002436338,0.004716766,0.008099773,0.009861773,0.006912949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005642914,"about_ca_system_score_gemma":0.02547866,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002680635,"about_ca_topic_score_gemma":0.003916674,"domain_scores_codex":[0.9331829,0.02942584,0.0206083,0.001943586,0.01179685,0.003042427],"domain_scores_gemma":[0.882741,0.03665122,0.02659616,0.004205026,0.04342588,0.006380774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001063184,0.0004244508,0.005504992,0.02672816,0.000597488,0.001364075,0.001335389,0.001686514,0.002725345,0.02062365,0.5500716,0.3878752],"study_design_scores_gemma":[0.0009626246,0.0006061888,0.008935323,0.06135451,0.0007437082,0.0009960129,0.001399844,0.0008910288,0.001403195,0.01986327,0.9026639,0.000180503],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"methods","genre_scores_codex":[0.008041372,0.1473096,0.03648452,0.6786963,0.03091743,0.01804048,0.005921647,0.0009645555,0.07362399],"genre_scores_gemma":[0.08774622,0.1056685,0.3356467,0.3694367,0.02137397,0.0237879,0.01500532,0.0004925685,0.0408423],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.1017129,"threshold_uncertainty_score":0.5379158,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04184898885750181,"score_gpt":0.3192135867304184,"score_spread":0.2773645978729166,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}